Estimating The Fair Value Of Genus plc (LON:GNS)
Apr 20
U.K. (FTSE) Biotech Industry Analysis
UpdatedApr 26, 2024
DataAggregated Company Financials
Companies28
- 7D-0.4%
- 3M-16.3%
- 1Y-29.1%
- YTDn/a
Over the last 7 days, the Biotech industry has remained flat. As for the longer term, the industry has declined 29% in the last year. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the U.K. Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Apr 2024 | UK£3.1b | UK£895.8m | -UK£215,522,918.68 | 30.2x | -14.2x | 3.4x |
| Sun, 24 Mar 2024 | UK£3.1b | UK£900.2m | -UK£203,996,663.16 | 34.5x | -15.4x | 3.5x |
| Tue, 20 Feb 2024 | UK£3.2b | UK£913.4m | -UK£198,099,118.55 | 30.7x | -16x | 3.5x |
| Thu, 18 Jan 2024 | UK£6.3b | UK£1.3b | -UK£245,367,125.00 | 37.9x | -25.9x | 5x |
| Sat, 16 Dec 2023 | UK£6.1b | UK£1.3b | -UK£245,410,787.00 | 37x | -25x | 4.8x |
| Mon, 13 Nov 2023 | UK£6.3b | UK£1.3b | -UK£243,279,195.00 | 37.1x | -25.9x | 5x |
| Wed, 11 Oct 2023 | UK£6.7b | UK£1.3b | -UK£250,659,034.00 | 38.3x | -26.6x | 5.2x |
| Fri, 08 Sep 2023 | UK£6.5b | UK£1.3b | -UK£205,785,130.00 | 23.6x | -31.6x | 5.2x |
| Sun, 06 Aug 2023 | UK£6.9b | UK£1.3b | -UK£209,148,186.00 | 23.6x | -32.8x | 5.4x |
| Tue, 04 Jul 2023 | UK£6.7b | UK£1.3b | -UK£209,150,813.00 | 23.9x | -31.9x | 5.3x |
| Thu, 01 Jun 2023 | UK£7.0b | UK£1.3b | -UK£204,864,951.00 | 23.1x | -34.1x | 5.5x |
| Sat, 29 Apr 2023 | UK£7.1b | UK£1.3b | -UK£175,242,186.00 | 23.6x | -40.3x | 5.6x |
| Mon, 27 Mar 2023 | UK£7.2b | UK£1.2b | -UK£155,777,625.00 | 25.3x | -46.3x | 5.8x |
| Wed, 22 Feb 2023 | UK£7.4b | UK£1.2b | -UK£149,846,857.00 | 27x | -49.2x | 6.3x |
| Fri, 20 Jan 2023 | UK£7.7b | UK£1.2b | -UK£140,151,449.00 | 27.7x | -54.9x | 6.6x |
| Sun, 18 Dec 2022 | UK£7.4b | UK£1.2b | -UK£138,023,426.00 | 25.6x | -53.6x | 6.4x |
| Tue, 15 Nov 2022 | UK£7.9b | UK£1.2b | -UK£140,941,466.00 | 24.4x | -56.2x | 6.8x |
| Thu, 13 Oct 2022 | UK£32.3b | UK£1.2b | -UK£151,081,464.00 | 26.2x | -214x | 27.8x |
| Sat, 10 Sep 2022 | UK£7.5b | UK£1.1b | -UK£145,040,999.00 | 35.2x | -51.5x | 6.5x |
| Mon, 08 Aug 2022 | UK£7.3b | UK£1.1b | -UK£201,439,580.00 | 37.6x | -36.4x | 6.6x |
| Wed, 06 Jul 2022 | UK£7.0b | UK£1.1b | -UK£176,078,893.00 | 36.2x | -39.6x | 6.3x |
| Fri, 03 Jun 2022 | UK£7.1b | UK£1.1b | -UK£153,008,288.00 | 37.9x | -46.7x | 6.4x |
| Sun, 01 May 2022 | UK£7.4b | UK£1.1b | -UK£139,125,640.00 | 36.6x | -53.3x | 6.7x |
| Tue, 29 Mar 2022 | UK£7.3b | UK£1.1b | -UK£81,395,845.00 | 41.1x | -89.4x | 6.7x |
| Thu, 24 Feb 2022 | UK£7.8b | UK£1.1b | -UK£119,742,231.00 | 32.6x | -65x | 7.2x |
| Sat, 22 Jan 2022 | UK£9.2b | UK£1.1b | -UK£123,455,728.00 | 42.3x | -74.2x | 8.4x |
| Mon, 20 Dec 2021 | UK£11.0b | UK£1.1b | -UK£121,081,863.00 | 49.7x | -90.6x | 10.1x |
| Wed, 17 Nov 2021 | UK£11.9b | UK£1.1b | -UK£149,752,597.00 | 69.8x | -79.6x | 11x |
| Fri, 15 Oct 2021 | UK£12.0b | UK£1.1b | -UK£148,394,388.00 | 70.4x | -81x | 10.9x |
| Sun, 12 Sep 2021 | UK£12.5b | UK£1.1b | -UK£143,503,184.62 | 52.8x | -86.9x | 11.8x |
| Tue, 10 Aug 2021 | UK£12.3b | UK£1.0b | -UK£172,541,949.91 | 29.9x | -71.2x | 12x |
| Mon, 03 May 2021 | UK£11.5b | UK£1.0b | -UK£166,311,048.52 | 30.3x | -69.3x | 11.4x |
Price to Earnings Ratio
-69.3x
Current Industry PE
- Investors are pessimistic on the British Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 7.5x is higher than the industry's current PS ratio of 3.4x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
- Revenues have also declined 4.1% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Biotech compare with similar industries?
| GB Market | 2.25% | |
| Healthcare | 7.50% | |
| Biotech | -0.37% | |
| Biotech | -0.37% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| AVCT Avacta Group | UK£0.45 | -7.2% UK£21.9m | -63.4% | PS10x | |
| OXB Oxford Biomedica | UK£2.20 | 8.4% +UK£17.0m | -49.3% | PS1.8x | |
| PRTC PureTech Health | UK£2.13 | 2.9% +UK£16.2m | 1.4% | PS215.7x | |
| NIOX NIOX Group | UK£0.68 | 4.6% +UK£12.7m | 46.3% | PE30.2x | |
| 4BB 4basebio | UK£11.20 | 8.2% +UK£10.9m | 75.0% | PS405.1x |